📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Advaxis

1.1 - Company Overview

Advaxis Logo

Advaxis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage immunotherapies for cancer and infectious diseases, based on a proprietary platform using live, attenuated bacteria engineered to secrete antigen/adjuvant fusion proteins to redirect the immune system to target and kill cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Advaxis

Genmab Logo

Genmab

HQ: Denmark Website
  • Description: Provider of fully human antibody therapeutics for potential cancer treatment, including investigational Rinatabart Sesutecan with promising anti-tumor activity in heavily pretreated ovarian and endometrial cancer patients; offers AI-powered target identification and candidate design, AI-enhanced clinical trial optimization, and collaboration with technology and academic organizations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genmab company profile →
Acambis Logo

Acambis

HQ: United Kingdom Website
  • Description: Provider of vaccine research, development and manufacturing for the prevention and treatment of infectious diseases in Europe and North America, offering ACAM2000, a smallpox vaccine for emergency-use stockpiling, and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acambis company profile →
T-knife Therapeutics Logo

T-knife Therapeutics

HQ: Germany Website
  • Description: Provider of T cell receptor-based therapies for cancer, using a humanized TCR mice platform carrying human TCRαβ gene loci to recombine a broad repertoire of human TCRs, enabling efficient generation and virtual selection of receptors targeting human tumor antigens.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full T-knife Therapeutics company profile →
Atreca Logo

Atreca

HQ: United States Website
  • Description: Provider of antibody discovery and development technologies that identify antibodies generated during immune responses from patient blood without prior antigen knowledge. Offers the Atreca Discovery Platform to generate clinical candidates and IRC single-B-cell sequencing; develops antibody-based oncology therapeutics; and partners in cancer immunotherapy, infectious disease, and autoimmune disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Atreca company profile →
Alzamend Neuro Logo

Alzamend Neuro

HQ: United States Website
  • Description: Provider of biotech therapies for Alzheimer's disease that develops and commercializes drugs, treatments, and cures. Includes AL001, an ionic cocrystal delivering lithium via lithium/proline/salicylate for Alzheimer's, bipolar disorder, major depressive disorder, and PTSD; and ALZN002, a cell-based therapeutic vaccine using a mutant-peptide sensitized cell to restore the patient's immune system's ability to combat Alzheimer's.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alzamend Neuro company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Advaxis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Advaxis

2.2 - Growth funds investing in similar companies to Advaxis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Advaxis

4.2 - Public trading comparable groups for Advaxis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Advaxis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Advaxis

What does Advaxis do?

Advaxis is a provider of clinical-stage immunotherapies for cancer and infectious diseases, based on a proprietary platform using live, attenuated bacteria engineered to secrete antigen/adjuvant fusion proteins to redirect the immune system to target and kill cancer.

Who are Advaxis's competitors?

Advaxis's competitors and similar companies include Genmab, Acambis, T-knife Therapeutics, Atreca, and Alzamend Neuro.

Where is Advaxis headquartered?

Advaxis is headquartered in United States.

How many employees does Advaxis have?

Advaxis has 1,000 employees 🔒.

When was Advaxis founded?

Advaxis was founded in 2010 🔒.

What sector and industry vertical is Advaxis in?

Advaxis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Advaxis

Who are the top strategic acquirers in Advaxis's sector and industry

Top strategic M&A buyers and acquirers in Advaxis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Advaxis?

Top strategic M&A buyers groups and sectors for Advaxis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Advaxis's sector and industry vertical

Which are the top PE firms investing in Advaxis's sector and industry vertical?

Top PE firms investing in Advaxis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Advaxis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Advaxis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Advaxis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Advaxis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Advaxis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Advaxis?

The key public trading comparables and valuation benchmarks for Advaxis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Advaxis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Advaxis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Advaxis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Advaxis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Advaxis's' sector and industry vertical?

Access recent funding rounds and capital raises in Advaxis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Advaxis